Our Experts

Work with Industry Thought Leaders at Every Stage of Your Clinical Research Study

With so much at stake, you want the best minds focused on your clinical trial. ERG delivers, with teams of experts working on every facet.

Andria Chastain

Chief Operating Officer, Evolution Research Group

  • Responsible for all clinical operations across the ERG portfolio, working closely with the medical and operational teams and bridging communication with the corporate leaders in finance, business development, and human capital
  • Industry veteran who oversaw clinical operations at several large multi-site SMOs  
  • Has worked on more than 100 early- to late-phase clinical trials
  • Provided clinical operations and project management services to Thievon-Wright and has been with ERG since its inception
  • Holds a degree from the University of North Carolina (BA, Psychology)

Clayton Dehn

Vice President of Clinical Pharmacology Services, Evolution Research Group

  • Published in numerous peer-reviewed journal articles
  • Conducted 160+ Phase I-IV clinical trials with challenging population inclusive of Diabetes, Vulvovaginal Candidiasis, Healthy Volunteers, Hypogonadal, Liver Disease, Coronary Artery Disease, NASH, Postpartum Depression, Alzheimer’s, and many other medical as well as psychiatric indications
  • Commissioner of the Arizona Biomedical Research Commission, Editor-In-Chief of Series of Endocrinology Diabetes and Metabolism and Editorial Board Member of various well-established journals

Ana Fuquay, MS, CCRC

Executive Director, Clinical Operations

  • Has participated in numerous late-phase clinical trials in CNS, with a focus on Alzheimer’s disease
  • Manages clinical and business operations at clinical trial sites in Delray Beach, FL and Stuart, FL
  • Holds degrees from Nova Southeastern University (MS, Mental Health Counseling) and Florida Atlantic University (BA)

Melissa Henry, RN, MSN, FNP, CCRC

Regional Director of Clinical Operations, Evolution Research Group

  • Regional Director of Clinical Operations at Evolution Research Group with 20+ years of experience
  • Holds degrees from the University of California at Los Angeles (MS) and the University of Southern California (BS)
  • Conducted 135+ Phase I-IV clinical trials with challenging populations inclusive of Major Depressive Disorder, ADHD, Alzheimer’s Disease, Fibromyalgia, Anxiety, Schizophrenia, Bipolar Disorder, Post Traumatic Stress Disorders, Migraines, Eating Disorders and various other psychiatric and neurological indications
  • Completed 25+ presentations at various annual research conference

Lauren Howard, BS

Regional Director, Evolution Research Group

  • Regional Director of Clinical Operations
  • 7+ years of experience in clinical research
  • Experienced in leading large teams performing phase I-IV clinical research in post operative pain, psychiatry, chronic pain, child/adolescent trials, and COVID vaccine and treatment trials

Joel Keller

Director, Patient Recruitment and Marketing, Evolution Research Group

  • Previously managed centralized patient recruitment and retention, enrolling trials at over 20 sites
  • Has served in a variety of media and marketing positions at an advertising agency, TV station and apparel company
  • Holds a BS, Communications/Marketing from the University of Illinois at Urbana-Champaign

Staci Maroney, MPH

Director of Regulatory Affairs, Evolution Research Group

  • Responsible for company-wide implementation and development of eRegulatory system, eRegulatory Work Instructions and onboard sites to eRegulatory system
  • Oversee maintenance of study documents in accord with FDA and other regulatory agency/guidance requirements
  • Holds Degrees from Johns Hopkins University School of Hygiene and Public Health (M.P.H.) and Trinity University (BA)
  • Published by the Academic Emergency Medicine journal

Ashley Poole, CCRC

Regional Director of Clinical Operations, Evolution Research Group

  • Industry leader in clinical trial site operations and day-to-day site management
  • Participated in more that 150 clinical trials in various therapeutic areas including psychiatry, pediatrics and pain
  • Frequently engaged to serve on advisory boards by sponsors working on programs addressing chronic mental illness
  • Holds a degree from the University of South Florida (BS)

Denise Roberts, RN, CCRC

Executive Director, Clinical Operations and Site Development, Evolution Research Group

  • Extensive experience with postoperative pain models, as well as multi-therapeutic indications, specializing in mitigating placebo response
  • Managed and participated in the clinical research of more than 225 Phase I, early- and late-phase trials in various therapeutic areas, including the following postoperative pain indications: abdominoplasty, third molar extraction, bunionectomy, and total knee replacement
  • Developed and manages ERG’s Postoperative Analgesic Program across multiple clinical trial sites
  • Responsible for the design and build-out of a 10,000-square-foot acute pain research facility, which includes two operating rooms and 24 beds
  • Holds a degree from Utah Valley State College (ADN, Registered Nurse), ACRP Certification and NIH Certification

Janeen Rosales

Vice President, Therapeutic Portfolio Lead

  • Executive Director of Operations
  • Has helped execute more than 250 clinical trials
  • Previously worked as the Chief Executive Officer for Research Centers of America
  • Experience overseeing divisions including Early and Late Phase Clinical Trial Implementation and Execution, Business Development, Quality Assurance/Control, Regulatory, Data Management, Marketing, Recruitment, Pharmacy and Laboratory Services
  • Certified Clinical Research Coordinator
  • Received her Master’s degree in Clinical Research Organization and Management from Drexel University School of Medicine; BS in Biology from Denison University

Cooper Shamblen

Vice President of Operations, Clinical Pharmacology of Miami

  • Involved in all aspects of study conduct for more than 1800 clinical trials with a focus on Phase I studies
  • Cofounder of Clinical Pharmacology Associates and Clinical Pharmacology of Miami

Adam Smith, PhD

Investigator, Site Director, Richmond Behavioral Associates

  • Investigator and Site Director at Richmond Behavioral Associates with 30+ years of experience
  • Has held various clinical positions such as program director, senior psychologist, and director
  • Holds Degrees from Nova Southeastern University (Ph.D), and Baruch College (MBA)
  • Has conducted 80+ clinical trials with challenging populations inclusive of Schizophrenia, ADHD, Bipolar Disorder, Anxiety, Major Depressive Disorder, Alzheimer’s Disease, Post Traumatic Stress Disorder, Obsessive Compulsive Disorder, treatment resistant disorders, and many other psychiatric and neurological indications

Lisa Wishard, RN, CCRC

Site Director, Finger Lakes Clinical Research

  • 20+ years of experience having worked on 100+ Phase I-IV clinical trials
  • Registered Nurse and Certified Clinical Research Coordinator